
    
      This study aims to evaluate the clinical safety and efficacy of the BTL-899 device for
      non-invasive lipolysis and fat reduction in the thigh and saddlebag area. This is a
      prospective, open-label, two-arm study; therefore the participants will be assigned to two
      study groups. Each participant will complete 4 treatment visits and 2 follow-up visits.
    
  